Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).
Polycystic ovary syndrome (PCOS), the most common endocrine disease among premenopausal women, is caused by both genes and environment. We and others previously reported association between single nucleotide polymorphisms (SNPs) in the DENND1A gene and PCOS. We therefore sequenced the DENND1A gene i...
Guardado en:
Autores principales: | Mette B Eriksen, Michael F B Nielsen, Klaus Brusgaard, Qihua Tan, Marianne S Andersen, Dorte Glintborg, Michael Gaster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97a3faecac2a4e6caa19e4bfdbb1ff8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics Characteristics of Clomiphene Citrate in Patients with Polycystic Ovary Syndrome (PCOS)
por: N Mirhosseini,, et al.
Publicado: (2011) -
Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
por: Vibe Skov, et al.
Publicado: (2008) -
Treatment pathways traversed by polycystic ovary syndrome (PCOS) patients: A mixed-method study.
por: Ishwarpreet Kaur, et al.
Publicado: (2021) -
Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.
por: Francisco Alvarez-Blasco, et al.
Publicado: (2009) -
Induction ovulation with use of low dose HMG in patients with Clomiphene Citrate resistant polycystic ovary syndrome (PCOs)
por: T Nazari, et al.
Publicado: (2003)